首页 | 本学科首页   官方微博 | 高级检索  
     


A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
Authors:Silverio Tomao  Adriana Romiti  Federica Tomao  Marisa Di Seri  Giuliana Caprio  Gian Paolo Spinelli  Edmondo Terzoli  Luigi Frati
Affiliation:(1) Department of Clinical Oncology, "Regina Elena" Cancer Institute of Rome, Via Chianesi, 53, 00100 Rome, Italy;(2) Department of Experimental Medicine and Pathology, University of Rome "La Sapienza", Viale Regina Elena 324, 00161 Rome, Italy;(3) Department of Medical Oncology, S.Andrea General Hospital, Via di Grottarossa, Rome, Italy
Abstract:

Background  

Many emerging new drugs have recently been trialled for treatment of early and advanced breast cancer. Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed and metastatic disease after failure of chemotherapy with antracyclines.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号